Therapeutic gene editing in haematological disorders with CRISPR/Cas9

TI Jensen, E Axelgaard, RO Bak - British journal of …, 2019 - Wiley Online Library
Summary The Clustered Regularly Interspaced Short Palindromic Repeats
(CRISPR)/CRISPR‐associated (Cas) 9 platform offers an efficient way of making precise …

Therapeutic gene editing in haematological disorders with CRISPR/Cas9

TI Jensen, E Axelgaard, RO Bak - British journal of …, 2019 - pubmed.ncbi.nlm.nih.gov
The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-
associated (Cas) 9 platform offers an efficient way of making precise genetic changes to the …

Therapeutic gene editing in haematological disorders with CRISPR/Cas9.

TI Jensen, E Axelgaard, RO Bak - British Journal of Haematology, 2019 - europepmc.org
Therapeutic gene editing in haematological disorders with CRISPR/Cas9. - Abstract - Europe
PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers …

[PDF][PDF] Therapeutic gene editing in haematological disorders with CRISPR/Cas9

TI Jensen, E Axelgaard, RO Bak - 2019 - researchgate.net
Summary The Clustered Regularly Interspaced Short Palindromic Repeats
(CRISPR)/CRISPR-associated (Cas) 9 platform offers an efficient way of making precise …

Therapeutic gene editing in haematological disorders with CRISPR/Cas9.

TI Jensen, E Axelgaard, RO Bak - British Journal of …, 2019 - search.ebscohost.com
The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR‐
associated (Cas) 9 platform offers an efficient way of making precise genetic changes to the …

Therapeutic gene editing in haematological disorders with CRISPR/Cas9

E Axelgaard, TI Jensen, RO Bak - British Journal of Haematology, 2019 - pure.au.dk
Abstract The Clustered Regularly Interspaced Short Palindromic Repeats
(CRISPR)/CRISPR-associated (Cas) 9 platform offers an efficient way of making precise …